Acute intracranial hypertension after nalidixic acid administration.
作者信息
Deonna T, Guignard J P
出版信息
Arch Dis Child. 1974 Sep;49(9):743. doi: 10.1136/adc.49.9.743.
Abstract
摘要
相似文献
1
Acute intracranial hypertension after nalidixic acid administration.服用萘啶酸后出现急性颅内高压。
Arch Dis Child. 1974 Sep;49(9):743. doi: 10.1136/adc.49.9.743.
2
Intracranial hypertension in nalidixic acid therapy.萘啶酸治疗中的颅内高压
Med J Aust. 1982 Mar 20;1(6):252. doi: 10.5694/j.1326-5377.1982.tb132291.x.
3
[A case of pseudotumor cerebri during treatment with nalidixic acid].
Minerva Pediatr. 1973 Jun 16;25(22):969-71.
4
Pseudotumor cerebri associated with nalidixic acid.与萘啶酸相关的假性脑瘤
Urology. 1974 Aug;4(2):204-7. doi: 10.1016/0090-4295(74)90335-5.
5
Benign intracranial hypertension after nalidixic acid overdose in infants.
Lancet. 1990 Jun 30;335(8705):1602. doi: 10.1016/0140-6736(90)91438-g.
6
Acute intracranial hypertension and nalidixic acid therapy.急性颅内高压与萘啶酸治疗
Neurology. 1982 Feb;32(2):212-5. doi: 10.1212/wnl.32.2.212.
7
Nalidixic acid (Negram) toxicity.萘啶酸（萘啶酮酸，Negram）中毒
Indian Pediatr. 1976 Apr;13(4):325.
8
[Convulsions with cerebrospinal fluid hypertension during treatment with nalidixic acid].
Minerva Pediatr. 1986 Sep 30;38(17-18):794-5.
9
Nalidixic acid induced pseudotumour cerebri in children.
J Indian Med Assoc. 1998 Oct;96(10):308, 314.
10
Intracranial hypertension and papilledema associated with nalidixic acid therapy.
Am J Ophthalmol. 1973 Nov;76(5):680-2. doi: 10.1016/0002-9394(73)90562-x.
引用本文的文献
1
Idiopathic Intracranial Hypertension in Neonates, Infants, and Toddlers.新生儿、婴儿和幼儿特发性颅内高压
J Clin Med. 2025 Jul 17;14(14):5084. doi: 10.3390/jcm14145084.
2
Idiopathic intracranial hypertension secondary to fluoroquinolone therapy: French pharmacovigilance data review.氟喹诺酮类药物治疗继发的特发性颅内高压：法国药物警戒数据回顾
Eur J Clin Microbiol Infect Dis. 2024 Feb;43(2):379-381. doi: 10.1007/s10096-023-04726-2. Epub 2023 Nov 24.
3
Acute Myeloid Leukemia Masquerading as Idiopathic Intracranial Hypertension: A Rare Initial Presentation.伪装成特发性颅内高压的急性髓系白血病：一种罕见的初始表现。
Kans J Med. 2021 May 21;14(2):133-135. doi: 10.17161/kjm.vol1413646. eCollection 2021.
4
Seizure activity and anion gap metabolic acidosis secondary to adverse effect of nalidixic acid-a case report.
Oxf Med Case Reports. 2021 Jan 12;2021(1):omaa120. doi: 10.1093/omcr/omaa120. eCollection 2021 Jan.
5
Idiopathic intracranial hypertension in the British population with obesity.肥胖人群中的英国特发性颅内高压症。
Acta Neurochir (Wien). 2019 Feb;161(2):239-246. doi: 10.1007/s00701-018-3772-9. Epub 2018 Dec 18.
6
Epidemiology and risk factors for idiopathic intracranial hypertension.特发性颅内高压的流行病学及危险因素
Int Ophthalmol Clin. 2014 Winter;54(1):1-11. doi: 10.1097/IIO.0b013e3182aabf11.
7
Idiopathic intracranial hypertension.特发性颅内高压。
Neurol Clin. 2010 Aug;28(3):593-617. doi: 10.1016/j.ncl.2010.03.003.
8
Clinical features and management of adverse effects of quinolone antibacterials.
Drug Saf. 1991 Jan-Feb;6(1):8-27. doi: 10.2165/00002018-199106010-00002.
本文引用的文献
1
Intracranial hypertension in a child during treatment with nalidixic acid.一名儿童在使用萘啶酸治疗期间出现颅内高压。
Br Med J. 1967 Jun 17;2(5554):744-5. doi: 10.1136/bmj.2.5554.744.
2
Childhood complications of nalidixic acid.萘啶酸的儿童期并发症
JAMA. 1971 May 10;216(6):1023-4.
3
[Acute and transitory intracranial hypertension in a 9-year-old child treated by nalidixic acid].[萘啶酸治疗一名9岁儿童的急性暂时性颅内高压]
Arch Fr Pediatr. 1972 Dec;29(10):1107-11.
Zotero 插件